Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 350 | 438↑25.1% | 499↑14.0% | 644↑29.1% | 732↑13.6% |
| Gross Profit | 143 | 200↑39.3% | 249↑24.6% | 351↑41.1% | 374↑6.5% |
| Operating Income | 11 | 70↑538.0% | 107↑53.8% | 197↑83.2% | 205↑4.3% |
| Net Income | 1 | 62↑4327.4% | 91↑47.1% | 138↑50.5% | 160↑16.0% |
| EBITDA | 30 | 112↑269.5% | 146↑31.0% | 240↑64.4% | 277↑15.4% |
| EPS Diluted | 0.03 | 1.25↑4270.6% | 1.74↑39.2% | 2.60↑49.4% | 3.06↑17.7% |